Monitoring by three laboratory methods of an oral GPIIb/IIIa anti-platelet agent in patients with vascular disease

被引：0
|
作者：
Ledford, MR
Canton, M
Preston, R
Gretler, DD
Enten, J
Alonso, A
Brito, MI
Delgado, L
Mitchell, M
机构：
[1] Univ Miami, Sch Med, Dept Pathol, Miami, FL 33152 USA
[2] Univ Miami, Sch Med, Dept Clin Pharmacol, Miami, FL 33152 USA
[3] Biocytex, Miami, FL USA
[4] COR Therapeut Inc, Marseille, France
[5] Beckman Coulter Corp, S San Francisco, CA USA
来源：
THROMBOSIS AND HAEMOSTASIS | 1999年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2601
引用
收藏
页码：821 / 821
页数：1
相关论文
共 50 条
  • [21] STUDIES OF PLATELET KINETICS IN PATIENTS WITH CARDIOVASCULAR-DISEASES, AND INFLUENCE OF ANTI-PLATELET AGENT RA 233
    ADAM, W
    SCHECK, R
    HERZ KREISLAUF, 1978, 10 (04): : 177 - 182
  • [22] The anti-platelet effect of aspirin in patients with end stage renal disease
    Faheem, O
    Shah, A
    Haider, J
    Schumacher, J
    Liang, T
    Azrin, M
    Bellumkonda, L
    Walsh, S
    Kaplan, A
    Liang, B
    FASEB JOURNAL, 2006, 20 (05): : A1139 - A1139
  • [23] SUSTAINED BUT VARIABLE INHIBITION OF PLATELET-AGGREGATION WITH XEMLOFIBAN, AN ORAL GPIIB/IIIA RECEPTOR ANTAGONIST, IN PATIENTS WITH UNSTABLE ANGINA
    KOTTKEMARCHANT, K
    SIMPFENDORFER, C
    LOWRIE, M
    BURNS, D
    ANDERS, RJ
    CIRCULATION, 1995, 92 (08) : 2331 - 2331
  • [24] Increased platelet reactivity in dyslipidemic patients with coronary artery disease on dual anti-platelet therapy
    Jaeger, Bernhard
    Piackova, Editha
    Haller, Paul Michael
    Andric, Tijana
    Kahl, Beatrice
    Christ, Guenther
    Geppert, Alexander
    Wojta, Johann
    Huber, Kurt
    ARCHIVES OF MEDICAL SCIENCE, 2019, 15 (01) : 65 - 71
  • [25] Timing of anti-platelet effect after oral aspirin administration in patients with sympathetic excitement
    Nishiyama, A
    Niikawa, O
    Mohri, H
    Tsushima, M
    CIRCULATION JOURNAL, 2003, 67 (08) : 697 - 700
  • [26] Effect of Oral Anti-platelet Regimens on Platelet Aggregation using Chronolog Light Transmittance Aggregometry in Coronary Heart Disease Patients: An Observational Study
    Kishan, P., V
    Kumar, Uday C.
    Shobha, J. C.
    Usharani, P.
    Chandrasekhar, E.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (11) : 2478 - 2482
  • [27] Anti-platelet or anti-coagulant agent for prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation, is it necessary?
    Chen, Jien-Jiun
    Lin, Lian-Yu
    Yang, Yao-Hsu
    Hwang, Juey-Jen
    Chen, Pau-Chung
    Lin, Jiunn-Lee
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 196 : 53 - 53
  • [28] Evaluation of anti-inflammatory effect of anti-platelet agent-clopidogrel in experimentally induced inflammatory bowel disease
    Patel, Samir H.
    Rachchh, Manish A.
    Jadav, Pinakin D.
    INDIAN JOURNAL OF PHARMACOLOGY, 2012, 44 (06): : 744 - 748
  • [29] Comparative of three methods (ELIZA, MAIPA and flow cytometry) to determine anti-platelet antibody in children with ITP
    Hamidpour, Mohsen
    Khalili, Ghader
    Tajic, Nader
    Shamsian, Bi Bi Shahin
    Hamidpour, Rafie
    AMERICAN JOURNAL OF BLOOD RESEARCH, 2014, 4 (02): : 86 - 92
  • [30] Pharmacist intervention and anti-platelet medication monitoring in patients following stroke and transient ischemic attack
    Greger, Jessica
    Wojcik, Rachael
    Westphal, Erica
    Aladeen, Traci
    Landolf, Kaitlin
    Boyce, Samantha
    Rainka, Michelle
    Gengo, Fran
    Bates, Vernice
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2021, 4 (03): : 311 - 317
12345